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Abstract
The most widely used ante-mortem diagnostic tests for tuberculosis in cattle are the tuber-
culin skin test and the interferon-gamma (IFN-γ) release assay, both of which measure cell-
mediated immune responses toMycobacterium bovis infection. However, limitations in the
performance of these tests results in a failure to identify all infected animals. In attempting to
increase the range of diagnostic tests for tuberculosis, measurement of the cytokine IP-10
in antigen-stimulated blood has previously been shown to improve the detection ofM.
tuberculosis andM. bovis infection, in humans and African buffaloes (Syncerus caffer),
respectively. In the present study, 60 cattle were identified by the single intradermal com-
parative tuberculin test as tuberculosis reactors (n = 24) or non-reactors (n = 36) and the
release of IFN-γ and IP-10 in antigen-stimulated whole blood from these animals was mea-
sured using bovine specific ELISAs. There was a strong correlation between IP-10 and IFN-
γ production in these samples. Moreover, measurement of the differential release of IP-10
in response to stimulation withM. bovis purified protein derivative (PPD) andM. avium PPD
distinguished between reactor and non-reactor cattle with a sensitivity of 100% (95% CI,
86%–100%) and a specificity of 97% (95% CI, 85%–100%). These results suggest that IP-
10 might prove valuable as a diagnostic biomarker ofM. bovis infection in cattle.
Introduction
Mycobacterium bovis is the principle causative agent of bovine tuberculosis (bTB), a chronic
granulomatous disease that can result in reduced productivity and death in cattle. Moreover,
becauseM. bovis-infected animals are a potential source of infection for humans the disease is
subject to comprehensive control measures in order to limit both zoonotic transmission and
economic losses. Such control is typically based on test-and-slaughter schemes, which require
the accurate diagnosis of infected animals.
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The tuberculin skin test is the most widely used test to detectM. bovis infection in cattle;
however, the more sensitive interferon-gamma (IFN-γ) release assay (IGRA) is used as an
ancillary ante-mortem test [1,2]. The latter assay detects the release of IFN-γ following anti-
genic stimulation of whole blood withM. bovis purified protein derivative (PPDb) [1,2]. The
PPDb comprises a complex mix of antigens that are not wholly specific toM. bovis and in
order to take account of cross-reactive sensitization to other mycobacteria, the specificity of the
assay is enhanced by comparing the PPDb-specific IFN-γ response with that in response toM.
avium PPD (PPDa). Alternatively, antigens that confer superior test specificity forM. bovis
andM. tuberculosis, i.e. early secretory antigenic target 6 kDa (ESAT-6) and culture filtrate
protein 10 kDa (CFP-10), have been incorporated into IGRAs [3]. However, the sensitivity of
these highly specific tests is lower than those using PPDb and PPDa [2,4,5].
One approach to improving the performance of such diagnostic assays is to identify addi-
tional biomarkers of immune activation. In humans, a number of alternatives to IFN-γ have
been evaluated for the diagnosis ofM. tuberculosis infection [6,7]. Of these, interferon gamma-
induced protein 10 (IP-10) has proven particularly noteworthy [7,8]. The production of IP-10
is strongly induced by IFN-γ in human antigen presenting cells [9] and human and murine
neutrophils [10,11]. Moreover, in cattle, transcription of the gene that encodes IP-10, i.e.
CXCL10, is induced by IFN-γ in endothelial cells [12] and is highly correlated with the tran-
scription of IFN-γmRNA in antigen-stimulated peripheral blood mononuclear cells [13]. In
bovids, ESAT-6/CFP-10 stimulation of whole blood fromM. bovis-infected African buffaloes
(Syncerus caffer) induced greater quantities of IP-10 than IFN-γ [14] and measurement of IP-
10 significantly increased the sensitivity of diagnosis of this infection [15]. In contrast, in a
study evaluating the diagnostic utility of this cytokine inM. bovis-infected cattle, IP-10 was not
found to be a useful biomarker [13]. However, it was suggested that this might have been a con-
sequence of limitations in the sensitivity of the enzyme-linked immunosorbent assay (ELISA)
used to measure this molecule [13]. Notably, this study employed a human IP-10 ELISA [13]
whereas the studies conducted in buffaloes used a commercially available bovine IP-10 assay
[14,15]. Given that the measurement of antigen-induced IP-10 might increase the diagnostic
sensitivity of tests ofM. bovis infection, the aim of the present study was to resolve these con-
flicting results by re-evaluating IP-10 as a biomarker forM. bovis infection in cattle using a
bovine-specific ELISA.
Materials and Methods
Animals
Cattle from herds naturally infected withM. bovis and cattle with no history ofM. bovis expo-
sure were tested using the single intradermal comparative tuberculin test (SICTT) as part of
the national bTB eradication programme. Animals were classified as either reactors (SICTT-
positive) or non-reactors (SICTT-negative) and assigned to 3 experimental groups. Group 1
consisted of twelve reactors, which were relocated and maintained at an approved research
farm facility. Water and food of the highest quality were provided at all times and animals were
cared for and monitored daily, with veterinary oversight according to approved standard oper-
ating procedures. There was no deviation from normal housing practices and animals were
never kept in isolation. When required, cattle were humanely slaughtered at an approved
slaughterhouse. Following slaughter, these animals presented with gross macroscopic lesions
consistent with advanced bTB and were confirmed as bTB-positive. Hereafter, an additional 12
reactor and 16 non-reactor cattle were randomly selected from anM. bovis-infected herd in the
national herd (Group 2) and were included in the study together with 20 non-reactor cattle
with no knownM. bovis exposure (Group 3). Heparinised blood samples for cytokine analysis
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were collected from all animals by a Senior Veterinary Inspector of the Irish Department of
Agriculture, Food & the Marine under a research license issued by the Department of Health &
Children. The study was approved by the UCD Animal Research Ethics Committee (AREC-P-
11-49-Gormley) and all diagnostic testing was conducted in accordance with regulations of the
EU trade Directive 64/432/EEC and the Irish bTB eradication programme.
Interferon gamma release assay
For each animal, 1.5 ml aliquots of heparinized blood in 24-well Costar tissue culture plates
(Corning Inc., Corning, NY, USA) were incubated for 24 h with, respectively, a 100 μl solution
of PPDb (final conc 20 μg/ml blood) (Thermo Fisher Scientific Prionics AG, Schlieren, Switzer-
land), a 100 μl solution of PPDa (10 μg/ml blood) (Thermo Fisher Scientific Prionics AG), and
100 μl phosphate buffered saline (PBS) as a non-stimulating control. For all bTB-positive ani-
mals, duplicate samples were incubated as described above for 48 h and additionally, 250 μl of
blood was cultured in 96-well plates (Corning Inc.) with 25 μl of PC-EC peptide cocktail at a
final concentration of 5 μg/ml blood (Thermo Fisher Scientific Prionics AG) for both 24 and
48 h. All blood cultures were incubated at 37°C in a humidified atmosphere with 5% CO2
before harvesting of plasma supernatants following centrifugation. The production of IFN-γ in
each sample was quantified in duplicate by sandwich ELISA [16] using a Bovigam1 ELISA kit
(Thermo Fisher Scientific Prionics AG) and the relative IFN-γ concentrations were recorded as
the optical density (OD) measured at 450 nm. Bovigam test results were calculated as the OD
derived from the PPDb-stimulated sample minus that derived from the PPDa-stimulated sam-
ple. A Bovigam result which was greater or equal to 0.1 was regarded as positive as per the
manufacturer’s recommendations.
IP-10 ELISA
The concentration of IP-10 in plasma samples generated as described above was measured as
follows. Anti-bovine CXCL10 antibody (Kingfisher Biotech Inc., St Paul, MN, USA) in PBS
(1 μg/ml; 100 μl/well) was incubated overnight at 4°C in 96-well Nunc Maxisorb microtitre
plates (Thermo Fisher Scientific, Waltham, MA, USA). Between subsequent steps, wells were
washed with Bovigam1Wash Buffer (Thermo Fisher Scientific Prionics AG) and all further
reactions were done at room temperature. Wells were blocked for 1 h with 200 μl Assay Buffer
consisting of 0.1% bovine serum albumin (Roche, Basel, Switzerland) and 0.05% Tween
(Sigma-Aldrich, St. Louis, MO, USA) in PBS. After blocking, plasma samples (diluted 1:5 in
Assay Buffer) were incubated in duplicate wells for 2 h (100 μl/well). Additionally, samples
from selected cattle were incubated in parallel with a dilution series of recombinant bovine
CXCL10 (Kingfisher Biotech Inc.). Hereafter, plates were incubated with biotinylated anti-
bovine CXCL10 antibody (Kingfisher Biotech Inc.), diluted in Assay Buffer (0.2 μg/ml) for 1 h
(100 μl/well) followed by incubation with Streptavidin-horse radish peroxidase (R & D sys-
tems, Minneapolis, MN, USA), diluted 1:200 in Assay Buffer, for 30 min (100 μl/well). After a
final wash step, Bovigam1 Chromogen substrate was added to each well for 30 min (100 μl/
well) before colour reactions were stopped with 50 μl Bovigam1 Stop Solution (both Thermo
Fisher Scientific Prionics AG). The optical density (OD) of each reaction was measured at 450
and 620 nm. For all animals, plasma IP-10 concentrations in each sample were recorded as the
OD value measured at 450 nm minus that measured at 620 nm.
Statistical analysis
For each group of animals, all plasma samples were assayed on the same occasion which
allowed for the comparison of relative IP-10 release under each experimental condition. The
IP-10 as a Biomarker of Bovine Tuberculosis
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M. bovis-specific IP-10 release was calculated as the concentration of plasma IP-10 from whole
blood stimulated with PC-EC peptides minus that in unstimulated blood (ΔEC) and the con-
centration of plasma IP-10 in blood incubated with PPDb corrected for the levels obtained fol-
lowing incubation with PPDa (ΔPPD). For selected animals, the OD values of a standard
dilution series of recombinant IP-10 were used to quantify IP-10 concentrations in PPDb- and
PPDa-stimulated blood samples by linear regression analysis. For these samples, the correla-
tion between IP-10 and IFN-γ release was calculated as Spearman's rank correlation coefficient.
Within animal groups, plasma IP-10 release under each experimental condition was compared
using the Wilcoxon signed rank test. To investigate the diagnostic potential of IP-10, the accu-
racy of a test utilizing the ΔPPD results for reactor and non-reactor cattle was determined
using receiver operating characteristic (ROC) curve analysis. The optimal cut off value for
ΔPPD was calculated as Youden’s Index [17]. All analyses were carried out using GraphPad
Prism Version 5.00 (GraphPad Software, Inc., La Jolla, CA, USA).
Results
Effect of antigen stimulation and incubation time on IP-10 release
In an initial study we measured IP-10 production in whole blood from 12 bTB-positive cattle
(Group 1) which was stimulated with antigen for 24 h and 48 h. Following incubation for 24 h,
IP-10 release in blood stimulated with PPDb and PC-EC peptides was significantly greater
when compared with that released in blood incubated with PBS (Fig 1a). The median IP-10
response in PPDb-stimulated samples was also significantly greater than in blood stimulated
with PPDa. In contrast, there was no significant difference in IP-10 responses in blood samples
incubated with PPDa and PBS (Fig 1a). At this time-point, all 12 bTB-positive animals showed
greater IP-10 release in response to PPDb stimulation compared to PPDa stimulation while 11/
12 animals showed greater IP-10 release in PC-EC peptide-stimulated blood compared with
unstimulated blood (Fig 1a).
Following 48 h of incubation, median levels of IP-10 release remained significantly greater
in PPDb- and PC-EC-stimulated blood compared to blood co-incubated with PBS and in
blood stimulated with PPDb compared to that stimulated with PPDa (Fig 1b). At this time
point, IP-10 release was greater in response to PPDb than to PPDa in 11/12 animals and
greater in PC-EC peptide-stimulated blood than unstimulated blood in 9/12 animals (Fig 1b).
For most animals, the release of IP-10 in blood cultured with PBS increased between 24 h and
48 h and median levels were significantly greater after 48 h of incubation when compared with
the earlier time point (Fig 2).
Antigen-specific IP-10 release in whole blood from reactor and non-
reactor cattle
In order to further characterize the antigen-specific release of IP-10, quantitative IP-10 levels
were compared in PPDb- and PPDa-stimulated blood from an additional 12 reactor and 16
non-reactor cattle from a herd with knownM. bovis infection (Group 2). In the reactor group,
the release of IP-10 was significantly greater in response to stimulation with PPDb (7500–
34800 pg/ml) than in response to PPDa (5200–15600 pg/ml) (Fig 3). In contrast, in the non-
reactor cattle, IP-10 responses to PPDb and PPDa ranged from 1400–8300 pg/ml and there
was no significant difference in IP-10 responses to these antigens (Fig 3).
We then investigated the relationship between IFN-γ and IP-10 release in these samples; we
limited our analysis to samples with IFN-γ OD values ranging from 0.1 to 2.5 (the linear range
IP-10 as a Biomarker of Bovine Tuberculosis
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of the ELISA). Within these limits, concentrations of IFN-γ and IP-10 were strongly correlated
(r = 0.65, n = 41, p< 0.0001; Fig 4).
Diagnostic potential of measuringM. bovis-specific IP-10 release
The potential diagnostic value of IP-10 was evaluated using ΔPPD results for all animals includ-
ing an additional 20M. bovis-unexposed cattle. All SICTT-positive cattle were Bovigam-positive
and all SICTT-negative animals were Bovigam-negative. Using ROC analysis, the ΔPPD results
for the 26 reactor and 36 non-reactor animals were compared and showed extremely good
agreement with the Bovigam assay and SICTT status of all animals (AUC = 1.00, p< 0.0001, S1
Fig). An optimal IP-10 ΔPPD cut-off value of 0.11 distinguished between reactors and non-reac-
tors with a sensitivity of 100% (95% CI, 86%–100%) and a specificity of 97% (95% CI, 85%–
100%) (Fig 5). This cut-off value assigned all but one of the Bovigam/SICTT-negative animals as
Fig 1. IP-10 release in response to antigenic stimulation after (A) 24 h and (B) 48 h.Whole blood from
bTB-positive cattle (n = 12) was incubated at 37°C with saline (PBS),M. avium PPD (PPDa),M. bovis PPD
(PPDb) and ESAT-6/CFP-10 peptides (EC). IP-10 release in whole blood in response to PPDb and EC was
significantly greater than that in blood co-incubated with PBS and significantly greater in response to PPDb
than in response to PPDa. Median values and the differential IP-10 responses to PPDa and PPDb (ΔPPD)
and PBS and EC (ΔEC) are shown (*, p < 0.01; **, p < 0.05).
doi:10.1371/journal.pone.0155440.g001
IP-10 as a Biomarker of Bovine Tuberculosis
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ΔPPD-negative (35/36). Changing the ΔPPD cut-off to 0.13 was the lowest value that had a
specificity of 100% (95% CI, 90%– 100%) and this identified reactor cattle with a sensitivity of
96% (95% CI, 79%– 100%).
Discussion
The most sensitive immunodiagnostic assays ofM. bovis infection in animals are those that
detect the activation of memory T-lymphocytes in response to stimulation with tuberculin
antigens [2]. In this study we have shown that the measurement of IP-10 release in whole
Fig 2. Spontaneous IP-10 release in whole blood from reactor cattle.Whole blood from cattle (n = 12)
was incubated with phosphate buffered saline for 24 and 48 h. IP-10 release showed a significant increase
over time (* < 0.005).
doi:10.1371/journal.pone.0155440.g002
Fig 3. IP-10 release in response to antigenic stimulation in reactor and non-reactor cattle.Whole blood
from non-reactor (n = 16) and reactor (n = 12) cattle was incubated withM. avium PPD (PPDa) andM. bovis
PPD (PPDb) for 24 h at 37°C. For reactor cattle, IP-10 release in response to PPDb was significantly greater
than that in response to PPDa. Median values are shown (*, p < 0.0005).
doi:10.1371/journal.pone.0155440.g003
IP-10 as a Biomarker of Bovine Tuberculosis
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blood of cattle is a sensitive marker of antigen recognition and immune activation and a prom-
ising diagnostic biomarker ofM. bovis infection.
The release of IP-10 was highly correlated with that of IFN-γ and after 24 h of blood culture,
all reactor cattle showed consistently greater PPDb-induced IP-10 responses when compared
with stimulation by PPDa. Moreover, as has been reported for humans [18] and African buffa-
loes [14], antigen-induced IP-10 was released at far greater concentrations than have previ-
ously been reported for IFN-γ [19,20]. Together, these findings are evidence that IP-10 is a
useful measure of antigen-specific cell mediated immunity in cattle. Because IP-10 is produced
Fig 4. Correlation between IFN-γ and IP-10 release.Whole blood from non-reactor and reactor cattle was
stimulated with eitherM. bovis PPD orM. avium PPD for 24 h at 37°C. The release of IFN-γ and IP-10 was
highly correlated in these samples (r = 0.65; p < 0.0001).
doi:10.1371/journal.pone.0155440.g004
Fig 5. Antigen-specific IP-10 release distinguishes between non-reactor and reactor cattle.Whole
blood from non-reactor (n = 36) and reactor cattle (n = 24) was incubated withM. bovis PPD andM. avium
PPD for 24 h at 37°C. The difference in IP-10 release in these samples (ΔPPD) was used to calculate, by
ROC analysis, an optimal cut off value of 0.11 (dotted line). This distinguished between these groups with a
sensitivity of 100% and a specificity of 97%.
doi:10.1371/journal.pone.0155440.g005
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in response to IFN-γ, we considered that the optimal incubation time of an assay measuring
this cytokine might be different than that for an IGRA. However, in the bTB-positive cohort,
the differential in the IP-10 response to PPDb and PPDa detected after 24 h of blood stimula-
tion diminished after 48 h of incubation. It is therefore possible that a shorter incubation time
might provide for even greater resolution between these responses, though this remains to be
determined. Nonetheless, measurement of ΔPPD after 24 h allowed for the highly accurate dis-
crimination between Bovigam/SICTT-positive and Bovigam/SICTT-negative animals and
indicates the potential of IP-10 as a highly specific diagnostic biomarker ofM. bovis infection
in cattle. Notably, selection of a ΔPPD threshold with a specificity of 100%, i.e. 0.13, distin-
guished between these groups with a sensitivity of 96% suggesting that this marker does not
significantly compromise diagnostic specificity in cattle. This finding is in agreement with
human studies that have shown IP-10 assays to have a specificity of close to 100% [8]. A more
sensitive cut-off value of 0.11 detected all Bovigam/SICTT-positive cattle and one additional
ΔPPD-positive individual. While the true infection status of this animal was not determined,
this result may indicate the potential for the IP-10 assay to increase the accuracy of diagnosis of
M. bovis infection in cattle.
The release of IP-10 also shows promise as a marker of immune sensitization to the highly
specificM. bovis proteins ESAT-6 and CFP-10. Importantly, measurement of IP-10, in combi-
nation with IFN-γ, has been shown to improve the detection of ESAT-6/CFP-10 sensitization
in humans and African buffaloes [6,15]. In cattle, use of these antigens would be particularly
useful for specifically detectingM. bovis-infected animals that have been vaccinated withM.
bovis BCG [21] and for testing herds with high rates of false positive reactions to standard PPD
assays [2]. However, in our study, the measurement of ESAT-6/CFP-10-specific IP-10, with
reference to levels of this cytokine in unstimulated blood, was in some cases compromised by
its release in control samples. The spontaneous production of IP-10 in blood from cattle has
previously been reported and may reflect the in vivo induction of this cytokine [13]. This is
consistent with findings from human studies that have identified a peripheral whole blood
gene transcription signature in tuberculosis patients that is dominated by a neutrophil-driven
interferon-inducible gene profile [22].
In other instances in the present study, IP-10 release in unstimulated blood exceeded that in
response to ESAT-6/CFP-10 and PPD. While the mechanism of this phenomenon is unclear,
the activation of antigen-specific memory lymphocytes may have resulted in reduced IP-10
production via the release of inhibitory cytokines, e.g. interleukin-10 [23]. Also, numerous pro-
teases are secreted from activated leukocytes and proteolysis of plasma IP-10 might obscure
detection of its release [24].
An earlier study with cattle experimentally infected withM. bovis found that IP-10 responses
to PPDb did not exceed the respective responses to medium alone at any time point over the
course of the infection [13]. This finding, in part, may have been a consequence of the high lev-
els of IP-10 measured in unstimulated control samples in that study. However, limitations in
the availability of suitable samples, and the use of a human ELISA, may have influenced these
earlier findings [13]. In the present study we used a bovine-specific ELISA to measure IP-10 and
showed that significant release of this protein occurs following antigenic stimulation of whole
blood of cattle.
The current study was not designed to determine the diagnostic performance of the IP-10
release assay in herds undergoing episodes of tuberculosis: the animals were recruited to the
study based on their skin test status. In infected herds, the IGRA is often used in parallel to the
skin test in order to maximise the detection of infected animals. Whether the IP-10 test can
detect additional infected animals that are undisclosed by current tests remains to be investi-
gated. In cases where the skin test and IGRA results are inconclusive, the measurement of IP-
IP-10 as a Biomarker of Bovine Tuberculosis
PLOS ONE | DOI:10.1371/journal.pone.0155440 May 11, 2016 8 / 10
10, which is produced in abundance in response to IFN-γ, might serve to amplify anM. bovis-
specific signal in an infected animal.
In summary, IP-10 release in stimulated whole blood is strongly correlated with that of
IFN-γ and is a robust biomarker of antigen-specific immunological memory in cattle. How-
ever, the spontaneous release of the cytokine in unstimulated blood requires further investiga-
tion in order to understand its origin and regulation as it might limit the performance of the
assay when utilizingM. bovis-specific antigens. Nonetheless, the release of IP-10 in response to
PPDb and PPDa antigens is a valuable biomarker ofM. bovis infection in cattle and measure-
ment of this cytokine might improve the diagnostic performance of whole blood stimulation
assays.
Supporting Information
S1 Fig. Measurement of antigen-specific IP-10 release shows extremely good agreement
with the Bovigam assay and single intradermal comparative tuberculin test (SICTT).
Whole blood from Bovigam/SICTT-negative (n = 36) and Bovigam/SICTT-positive cattle
(n = 24) was incubated withM. bovis PPD andM. avium PPD for 24 h at 37°C and the differ-
ence in IP-10 release in these samples (ΔPPD) was determined by ELISA. The ΔPPD results for
cattle from each group were compared by ROC curve analysis and IP-10 test outcomes showed
extremely good agreement with the reference tests.
(TIF)
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